Ongoing Projects
- The role of TGF-β-induced microRNAs in pancreatic cancer
- Use of nanoparticles for delivery of anti-miRNAs in pancreatic cancer
- CRISPR/Cas9 screening to identify functional microRNA targets
- MicroRNAs as biomarkers for COVID-19 disease
- Investigating tumour heterogeneity using single-cell RNA sequencing
Reviewer for Following Journals
Guest Lectures
Baricitinib: computer to FDA approval in 10 months, Imperial College London, Drug Discovery Symposium, 2021
miRNAs in pancreatic cancer: from discovery to function, NanoString, Webinar, 2020
The role of non-coding RNAs regulated by TGF-β in controlling pancreatic cancer progression, Precision CRISPR EU, London, 2018
Investigating the role of microRNAs in pancreatic cancer progression, ThermoFisher Scientific, Webinar, 2018
Research Student Supervision
Chakravarthy,Y, Inhibition of microRNAs synergistically inhibits tumour growth in KPC mice derived CHX-Luc cell line
Fan,H, Developing an high throughut genome-wide screen to identify functional microRNAs targets that promote stemness in pancreatic cancer using CRISPR-Cas9
Psujek,M, The evaluation of miR-100 and/or miR-125b inhibition as a novel therapeutic approach for pancreatic cancer,